$IRWD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IRONWOOD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IRONWOOD PHARMACEUTICALS INC. Get notifications about new insider transactions in IRONWOOD PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 18.29 | 136 | 2,487 | 15,157 | 15 K to 15.2 K (+0.91 %) |
Mar 29 2013 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | J | 0.00 | 615 | 0 | 73,418 | 72.8 K to 73.4 K (+0.84 %) |
Mar 29 2013 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 136 | 0 | 54,095 | 54 K to 54.1 K (+0.25 %) |
Mar 29 2013 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 136 | 0 | 5,906 | 5.8 K to 5.9 K (+2.36 %) |
Mar 25 2013 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 0.00 | 240,100 | 0 | 995,804 | 1.2 M to 995.8 K (-19.43 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VHCP Co-Investment Holdings, L ... | 10% Owner | Buy | J | 0.00 | 18,910 | 0 | 18,910 | 0 to 18.9 K |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VHCP Co-Investment Holdings, L ... | 10% Owner | Buy | J | 0.00 | 7,483 | 0 | 7,483 | 0 to 7.5 K |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VHCP Co-Investment Holdings, L ... | 10% Owner | Buy | J | 0.00 | 88,262 | 0 | 88,262 | 0 to 88.3 K |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VHCP Co-Investment Holdings, L ... | 10% Owner | Sell | J | 0.00 | 95,745 | 0 | 287,234 | 383 K to 287.2 K (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VHCP Co-Investment Holdings, L ... | 10% Owner | Sell | J | 0.00 | 504,255 | 0 | 1,512,766 | 2 M to 1.5 M (-25.00 %) |
Mar 21 2013 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Buy | J | 0.00 | 180 | 0 | 53,959 | 53.8 K to 54 K (+0.33 %) |
Mar 20 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 105 | 0 | 105 | 0 to 105 |
Mar 20 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 12,097 | 0 | 36,290 | 48.4 K to 36.3 K (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 225 | 0 | 2,442 | 2.2 K to 2.4 K (+10.15 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 225 | 0 | 225 | 0 to 225 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 195 | 0 | 2,217 | 2 K to 2.2 K (+9.64 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 195 | 0 | 195 | 0 to 195 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 181 | 0 | 2,022 | 1.8 K to 2 K (+9.83 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 181 | 0 | 181 | 0 to 181 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 187 | 0 | 1,841 | 1.7 K to 1.8 K (+11.31 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 187 | 0 | 187 | 0 to 187 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 208 | 0 | 1,654 | 1.4 K to 1.7 K (+14.38 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 208 | 0 | 208 | 0 to 208 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 231 | 0 | 1,446 | 1.2 K to 1.4 K (+19.01 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 231 | 0 | 231 | 0 to 231 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 159 | 0 | 1,215 | 1.1 K to 1.2 K (+15.06 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 159 | 0 | 159 | 0 to 159 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 178 | 0 | 1,056 | 878 to 1.1 K (+20.27 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 178 | 0 | 178 | 0 to 178 |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 241 | 0 | 878 | 637 to 878 (+37.83 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 21 | 0 | 15,021 | 15 K to 15 K (+0.14 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 18,910 | 0 | 18,910 | 0 to 18.9 K |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 7,483 | 0 | 7,483 | 0 to 7.5 K |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 88,262 | 0 | 88,262 | 0 to 88.3 K |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 95,745 | 0 | 287,234 | 383 K to 287.2 K (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 504,255 | 0 | 1,512,766 | 2 M to 1.5 M (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 920,832 | 0 | 2,762,497 | 3.7 M to 2.8 M (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 639,901 | 0 | 1,919,704 | 2.6 M to 1.9 M (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VENROCK ASSOCIATES | 10% Owner | Sell | J | 0.00 | 920,832 | 0 | 2,762,497 | 3.7 M to 2.8 M (-25.00 %) |
Mar 19 2013 | IRWD | IRONWOOD PHARMACEU ... | VENROCK ASSOCIATES | 10% Owner | Sell | J | 0.00 | 639,901 | 0 | 1,919,704 | 2.6 M to 1.9 M (-25.00 %) |
Mar 13 2013 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | M | 5.48 | 40,000 | 219,200 | 160,000 | |
Mar 13 2013 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 17.00 | 40,000 | 680,000 | 0 | 40 K to 0 (-100.00 %) |
Mar 13 2013 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Buy | M | 5.48 | 40,000 | 219,200 | 40,000 | 0 to 40 K |
Mar 07 2013 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | M | 0.60 | 100,000 | 60,000 | 33,334 | |
Mar 07 2013 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Buy | M | 0.60 | 100,000 | 60,000 | 241,666 | 141.7 K to 241.7 K (+70.59 %) |
Mar 07 2013 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Sell | S | 15.57 | 50,000 | 778,500 | 141,666 | 191.7 K to 141.7 K (-26.09 %) |
Mar 05 2013 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Buy | J | 0.00 | 2,304 | 0 | 43,239 | 40.9 K to 43.2 K (+5.63 %) |
Mar 05 2013 | IRWD | IRONWOOD PHARMACEU ... | Owens Edward P | Director | Grant | A | 0.00 | 8,333 | 0 | 88,333 | 80 K to 88.3 K (+10.42 %) |
Feb 21 2013 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 25,000 | 15,000 | 35,000 | |
Feb 21 2013 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 75,000 | 45,000 | 0 | |
Feb 21 2013 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 25,000 | 15,000 | 310,000 | 285 K to 310 K (+8.77 %) |
Feb 21 2013 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 75,000 | 45,000 | 285,000 | 210 K to 285 K (+35.71 %) |
Feb 05 2013 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 13.08 | 110,000 | 1,438,800 | 110,000 | |
Feb 05 2013 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | A | 13.08 | 90,000 | 1,177,200 | 90,000 | |
Feb 05 2013 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 13.08 | 110,000 | 1,438,800 | 110,000 | |
Feb 05 2013 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 13.08 | 90,000 | 1,177,200 | 90,000 | |
Jan 03 2013 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 11.08 | 225 | 2,493 | 15,788 | 15.6 K to 15.8 K (+1.45 %) |
Feb 05 2013 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 13.08 | 375,000 | 4,905,000 | 375,000 | |
Jan 03 2013 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 225 | 0 | 5,770 | 5.5 K to 5.8 K (+4.06 %) |
Jan 03 2013 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Gift | G | 0.00 | 52,356 | 0 | 324,729 | 377.1 K to 324.7 K (-13.88 %) |
Jan 03 2013 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 225 | 0 | 53,779 | 53.6 K to 53.8 K (+0.42 %) |
Dec 31 2012 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 31,974 | 0 | 40,935 | 72.9 K to 40.9 K (-43.85 %) |
Dec 20 2012 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 25,000 | 0 | 72,909 | 97.9 K to 72.9 K (-25.53 %) |
Dec 06 2012 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 4,000 | 0 | 97,909 | 101.9 K to 97.9 K (-3.93 %) |
Dec 05 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Buy | J | 0.00 | 1,664 | 0 | 5,545 | 3.9 K to 5.5 K (+42.88 %) |
Dec 05 2012 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 143 | 0 | 826 | 683 to 826 (+20.94 %) |
Dec 05 2012 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 247 | 0 | 1,482 | 1.2 K to 1.5 K (+20.00 %) |
Nov 21 2012 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Option Exercise | M | 0.60 | 40,000 | 24,000 | 0 | |
Nov 21 2012 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Buy | M | 0.60 | 40,000 | 24,000 | 101,909 | 61.9 K to 101.9 K (+64.61 %) |
Nov 19 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Buy | J | 0.00 | 1,664 | 0 | 3,881 | 2.2 K to 3.9 K (+75.06 %) |
Nov 19 2012 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 136 | 0 | 683 | 547 to 683 (+24.86 %) |
Nov 19 2012 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 247 | 0 | 1,235 | 988 to 1.2 K (+25.00 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 4.89 | 10,000 | 48,900 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 4.33 | 10,000 | 43,300 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 3.76 | 10,000 | 37,600 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 1.56 | 10,000 | 15,600 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.60 | 10,000 | 6,000 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.60 | 10,000 | 6,000 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.60 | 15,000 | 9,000 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.60 | 10,000 | 6,000 | 0 | |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 4.89 | 10,000 | 48,900 | 358,026 | 348 K to 358 K (+2.87 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 4.33 | 10,000 | 43,300 | 348,026 | 338 K to 348 K (+2.96 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 3.76 | 10,000 | 37,600 | 338,026 | 328 K to 338 K (+3.05 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 1.56 | 10,000 | 15,600 | 328,026 | 318 K to 328 K (+3.14 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 0.60 | 10,000 | 6,000 | 318,026 | 308 K to 318 K (+3.25 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 0.60 | 10,000 | 6,000 | 308,026 | 298 K to 308 K (+3.36 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 0.60 | 15,000 | 9,000 | 298,026 | 283 K to 298 K (+5.30 %) |
Nov 08 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 0.60 | 10,000 | 6,000 | 283,026 | 273 K to 283 K (+3.66 %) |
Nov 06 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | P | 11.65 | 50,000 | 582,500 | 72,803 | 22.8 K to 72.8 K (+219.27 %) |
Oct 26 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Gift | G | 0.00 | 6,656 | 0 | 2,217 | 8.9 K to 2.2 K (-75.01 %) |
Oct 15 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.13 | 35,153 | 461,541 | 1,235,904 | 1.3 M to 1.2 M (-2.77 %) |
Oct 15 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.37 | 118,220 | 1,580,743 | 1,271,057 | 1.4 M to 1.3 M (-8.51 %) |
Oct 15 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.08 | 59,502 | 778,310 | 1,389,277 | 1.4 M to 1.4 M (-4.11 %) |
Oct 09 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.00 | 5,878 | 76,432 | 1,448,779 | 1.5 M to 1.4 M (-0.40 %) |
Oct 09 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.02 | 12,727 | 165,746 | 1,454,657 | 1.5 M to 1.5 M (-0.87 %) |
Oct 09 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.00 | 700 | 9,100 | 1,467,384 | 1.5 M to 1.5 M (-0.05 %) |
Oct 03 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.00 | 6,300 | 81,900 | 1,468,084 | 1.5 M to 1.5 M (-0.43 %) |
Oct 03 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.02 | 2,100 | 27,333 | 1,474,384 | 1.5 M to 1.5 M (-0.14 %) |
Oct 02 2012 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 12.78 | 195 | 2,492 | 15,563 | 15.4 K to 15.6 K (+1.27 %) |
Oct 02 2012 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 195 | 0 | 53,554 | 53.4 K to 53.6 K (+0.37 %) |
Oct 02 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 195 | 0 | 8,873 | 8.7 K to 8.9 K (+2.25 %) |
Sep 28 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.24 | 43,622 | 577,342 | 1,476,484 | 1.5 M to 1.5 M (-2.87 %) |
Sep 28 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.20 | 51,073 | 674,363 | 1,520,106 | 1.6 M to 1.5 M (-3.25 %) |
Sep 25 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.88 | 36,056 | 500,634 | 1,571,179 | 1.6 M to 1.6 M (-2.24 %) |
Sep 25 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 14.09 | 80,409 | 1,133,011 | 1,607,235 | 1.7 M to 1.6 M (-4.76 %) |
Sep 25 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 14.89 | 119,221 | 1,775,070 | 1,806,865 | 1.9 M to 1.8 M (-6.19 %) |
Sep 20 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.75 | 53,342 | 733,613 | 1,806,865 | 1.9 M to 1.8 M (-2.87 %) |
Sep 20 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.34 | 55,878 | 745,379 | 1,860,207 | 1.9 M to 1.9 M (-2.92 %) |
Sep 20 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.53 | 49,113 | 664,317 | 1,916,085 | 2 M to 1.9 M (-2.50 %) |
Sep 17 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Buy | J | 0.00 | 1,664 | 0 | 8,678 | 7 K to 8.7 K (+23.72 %) |
Sep 17 2012 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 136 | 0 | 547 | 411 to 547 (+33.09 %) |
Sep 17 2012 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 247 | 0 | 988 | 741 to 988 (+33.33 %) |
Sep 04 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.16 | 24,100 | 317,120 | 2,118,974 | 2.1 M to 2.1 M (-1.12 %) |
Sep 17 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.22 | 39,337 | 519,909 | 1,965,198 | 2 M to 2 M (-1.96 %) |
Sep 17 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.14 | 84,925 | 1,115,719 | 2,004,535 | 2.1 M to 2 M (-4.06 %) |
Sep 17 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.06 | 29,514 | 385,491 | 2,089,460 | 2.1 M to 2.1 M (-1.39 %) |
Aug 17 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 970 | 0 | 2,985 | 2 K to 3 K (+48.14 %) |
Aug 17 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 970 | 0 | 2,985 | 2 K to 3 K (+48.14 %) |
Aug 17 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 970 | 0 | 2,985 | 2 K to 3 K (+48.14 %) |
Aug 01 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.09 | 5,345 | 69,971 | 2,143,074 | 2.1 M to 2.1 M (-0.25 %) |
Aug 01 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.26 | 2,100 | 27,839 | 2,148,419 | 2.2 M to 2.1 M (-0.10 %) |
Jul 30 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.38 | 41,419 | 554,012 | 2,150,519 | 2.2 M to 2.2 M (-1.89 %) |
Jul 30 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.07 | 17,261 | 225,624 | 2,191,938 | 2.2 M to 2.2 M (-0.78 %) |
Jul 30 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.00 | 200 | 2,600 | 2,209,199 | 2.2 M to 2.2 M (-0.01 %) |
Jul 24 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.01 | 6,900 | 89,743 | 2,209,399 | 2.2 M to 2.2 M (-0.31 %) |
Jul 24 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.08 | 16,040 | 209,882 | 2,216,299 | 2.2 M to 2.2 M (-0.72 %) |
Jul 20 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.35 | 47,252 | 630,828 | 2,232,363 | 2.3 M to 2.2 M (-2.07 %) |
Jul 20 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.40 | 18,060 | 242,029 | 2,279,615 | 2.3 M to 2.3 M (-0.79 %) |
Jul 20 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.63 | 7,903 | 107,716 | 2,297,675 | 2.3 M to 2.3 M (-0.34 %) |
Jul 16 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.80 | 14,708 | 202,956 | 2,305,578 | 2.3 M to 2.3 M (-0.63 %) |
Jul 16 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.78 | 20,005 | 275,673 | 2,320,286 | 2.3 M to 2.3 M (-0.85 %) |
Jul 16 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.33 | 600 | 7,999 | 2,340,291 | 2.3 M to 2.3 M (-0.03 %) |
Jul 11 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.86 | 4,900 | 67,934 | 2,340,891 | 2.3 M to 2.3 M (-0.21 %) |
Jul 11 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.77 | 14,055 | 193,497 | 2,345,791 | 2.4 M to 2.3 M (-0.60 %) |
Jul 06 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.90 | 18,065 | 251,125 | 2,359,846 | 2.4 M to 2.4 M (-0.76 %) |
Jul 06 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 14.00 | 16,960 | 237,423 | 2,377,911 | 2.4 M to 2.4 M (-0.71 %) |
Jul 06 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.96 | 9,392 | 131,107 | 2,394,871 | 2.4 M to 2.4 M (-0.39 %) |
Jul 03 2012 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 181 | 0 | 53,359 | 53.2 K to 53.4 K (+0.34 %) |
Jul 03 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 181 | 0 | 7,014 | 6.8 K to 7 K (+2.65 %) |
Jul 02 2012 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 13.78 | 181 | 2,494 | 15,368 | 15.2 K to 15.4 K (+1.19 %) |
Jul 02 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.92 | 14,700 | 204,624 | 2,404,263 | 2.4 M to 2.4 M (-0.61 %) |
Jul 02 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.77 | 36,600 | 503,982 | 2,418,963 | 2.5 M to 2.4 M (-1.49 %) |
Jul 02 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Sell | S | 13.94 | 5,274 | 73,520 | 2,455,563 | 2.5 M to 2.5 M (-0.21 %) |
Jun 08 2012 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Option Exercise | C | 0.00 | 15,000 | 0 | 0 | |
Jun 08 2012 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | C | 0.00 | 15,000 | 0 | 15,187 | 187 to 15.2 K (+8,021.39 %) |
Apr 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | M | 0.41 | 100,000 | 41,000 | 0 | |
Apr 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | M | 0.41 | 50,000 | 20,500 | 0 | |
Apr 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | M | 0.41 | 100,000 | 41,000 | 3,649,751 | 3.5 M to 3.6 M (+2.82 %) |
Apr 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | M | 0.41 | 50,000 | 20,500 | 3,549,751 | 3.5 M to 3.5 M (+1.43 %) |
Apr 03 2012 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 13.31 | 187 | 2,489 | 187 | 0 to 187 |